|
Market Closed -
Nasdaq
23:00:00 28/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 4.040 USD | +7.45% |
|
+5.48% | -19.52% |
| 09-24 | Annexon, Inc. Announces Oral Presentations On Vonaprument At The Retina Society 59th Annual Scientific Meeting | CI |
| 08-12 | Annexon, Inc., Q2 2026 Earnings Call, Aug 12, 2026 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ANNEXON, INC. | Bio Therapeutic Drugs | +7.45% | +5.48% | -19.52% | +14.12% | -76.33% | 713M |  |  | |
- Stock Market
- Stocks
- ANNX Stock
- Charts Annexon, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
